Lewis Williams - Director, Five Prime Therapeutics, Inc

As of September 4, 2019


Lewis Williams Net Worth

  • Net worth is estimated to be at least $16.82M
  • Owns at least 433,892 units of Five Prime Therapeutics, Inc stock
  • Sold an estimated value of $18M in the last 4 years at Five Prime Therapeutics, Inc

Lewis Williams Trading

  • Largest purchase of shares was 52,801 units , worth over $448.28K on April 7, 2016
  • Largest sale of shares was 71,229 units , worth over $2.38M on February 8, 2016
  • In total has made about 33 transactions over 4 years
  • Usually trades in February and September, with the busiest year in 2016
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Lewis Williams Mailing Address

  • Mailing address is C/o Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco CA 94080 CA

Five Prime Therapeutics, Inc Insider Trading

  • The most recent transaction was 7,393,340 units sold on November 13, 2020 by Pil Partners Bvf, Fund Value Biotechnology, Bvf I GP Llc, Biotechnology Value Fund Ii Lp, Bvf Ii GP Llc, Biotechnology Value Trading Fund Os Lp, Bvf Partners Os Ltd, Bvf GP Holdings Llc, Incil Bvf and Mark Lampert worth over $149.25M
  • In the last 5 years, insiders at Five Prime Therapeutics, Inc sold an estimated value of $191.93M and bought an estimated value of $25.9M
  • The most active traders are Marc Aron Knickerbocker, President & CEO,  Lewis Williams, Director,  and William Ringo, Director
  • Insider trading is most common in May, with the busiest year in 2016

FIVE PRIME THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1